MedTrace Logo

Technology-assisted Blended Learning on Motivational Interviewing for Mental Health Nurses and Its Clinical Impact

NCT06004492 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 274

Last updated 2024-12-12

No results posted yet for this study

Summary

Medication adherence is the primary care to stabilize the symptoms of patients with schizophrenia, but more than half of community patients still do not adhere to medication. According to the latest research of our team, the motivational interviewing may be more effective in promoting medication adherence than the insight. In the past, there was a lack of theoretical and empirical motivational interviewing and integrated medication adherence program. Therefore, the first year of this plan has completed the construction of integrated medication adherence. Considering the current lack of training and promotion of the blended learning model assisted by convenient and effective mobile technology.

Aim: To develop and evaluate the effectiveness of an integrated program combining technology-assisted blended learning on motivational interviewing knowledge, skills, and self-efficacy for psychiatric mental health nurses, and its clinical impact.

Conditions

  • Nurse's Role

Interventions

BEHAVIORAL

blended learning program

blended learning program: 8 hours of workshops and four months of practical learning on technology platforms.

Sponsors & Collaborators

  • National Taipei University of Nursing and Health Sciences

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-08
Primary Completion
2023-08-31
Completion
2024-08-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06004492 on ClinicalTrials.gov